Alpha Teknova Inc. (NASDAQ: TKNO)
$7.9900
+0.0800 ( -1.96% ) 92.5K
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.
Market Data
Open
$7.9900
Previous close
$7.9100
Volume
92.5K
Market cap
$424.86M
Day range
$7.7810 - $8.5500
52 week range
$1.1550 - $9.7200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 78 | Nov 08, 2024 |
8-k | 8K-related | 13 | Nov 07, 2024 |
8-k | 8K-related | 13 | Aug 13, 2024 |
10-q | Quarterly Reports | 77 | Aug 13, 2024 |
4 | Insider transactions | 1 | Jul 16, 2024 |
4 | Insider transactions | 1 | Jul 16, 2024 |
4 | Insider transactions | 1 | Jul 16, 2024 |
8-k | 8K-related | 15 | Jul 12, 2024 |
8-k | 8K-related | 13 | Jul 09, 2024 |
8-k | 8K-related | 11 | Jul 01, 2024 |